Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024680
Filing Date
2022-11-14
Accepted
2022-11-14 07:17:44
Documents
91
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-20220930.htm   iXBRL 10-Q 3442214
2 EX-3.1 syrs-ex3_1.htm EX-3.1 304072
3 EX-10.8 syrs-ex10_8.htm EX-10.8 82882
4 EX-10.10 syrs-ex10_10.htm EX-10.10 75764
5 EX-10.11 syrs-ex10_11.htm EX-10.11 67068
6 EX-10.12 syrs-ex10_12.htm EX-10.12 51156
7 EX-10.13 syrs-ex10_13.htm EX-10.13 56721
8 EX-31.1 syrs-ex31_1.htm EX-31.1 20652
9 EX-31.2 syrs-ex31_2.htm EX-31.2 20614
10 EX-32.1 syrs-ex32_1.htm EX-32.1 10834
11 EX-32.2 syrs-ex32_2.htm EX-32.2 10782
  Complete submission text file 0000950170-22-024680.txt   13784834

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT syrs-20220930_cal.xml EX-101.CAL 64396
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT syrs-20220930_pre.xml EX-101.PRE 495801
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT syrs-20220930_def.xml EX-101.DEF 302685
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT syrs-20220930.xsd EX-101.SCH 81125
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT syrs-20220930_lab.xml EX-101.LAB 603026
85 EXTRACTED XBRL INSTANCE DOCUMENT syrs-20220930_htm.xml XML 2752963
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 221380181
SIC: 2834 Pharmaceutical Preparations